ReachMD

Episodes 1-15 of 22

• • 

    

    Richard S. Finn, MD

    Peer

  • 

    

    Amit Singal, MD, MS

    Peer

  • 

    

    Mark Yarchoan, MD

    Peer

  4

  

  RestartResume

  Unresectable HCC: An Emerging Era of Combination Therapy – A Clinical Convergence^®

  Unresectable HCC: An Emerging Era of Combination Therapy – A Clinical Convergence^®

  0.75 credits

• • 

    

    David P. Hudesman, MD

    Peer

  4

  

  RestartResume

  Virtual IBD Clinic: Disease Management and Surgery

  Virtual IBD Clinic: Disease Management and Surgery

  0.75 credits

• • 

    

    Anita Afzali, MD, MPH, FACG

    Peer

  13

  

  RestartResume

  Virtual IBD Clinic: Diagnosis and Medical Treatment

  Virtual IBD Clinic: Diagnosis and Medical Treatment

  0.75 credits

• • 

    

    Peter A. Lio, MD

    Peer

  • 

    

    Mark Boguniewicz, MD

    Peer

  • 

    

    Eric Simpson, MD, MCR

    Peer

  9

  

  RestartResume

  Combining Biologics in a Young Patient with Atopic Dermatitis

  Combining Biologics in a Young Patient with Atopic Dermatitis

  0.25 credits

• • 

    

    Reynold A. Panettieri Jr., MD

    Peer

  • 

    

    Michael E. Wechsler, MD, MMSc

    Peer

  • 

    

    Jonathan Corren, MD

    Peer

  5

  

  RestartResume

  Patient with Asthma Suffering from Treatment-Related Conjunctivitis: Clinical Consults

  Patient with Asthma Suffering from Treatment-Related Conjunctivitis: Clinical Consults

  0.25 credits

• • 

    

    Reynold A. Panettieri Jr., MD

    Peer

  • 

    

    Michael E. Wechsler, MD, MMSc

    Peer

  • 

    

    Jonathan Corren, MD

    Peer

  6

  

  RestartResume

  Patient with Uncontrolled Asthma While on a Biologic: Clinical Consults

  Patient with Uncontrolled Asthma While on a Biologic: Clinical Consults

  0.25 credits

• • 

    

    Peter A. Lio, MD

    Peer

  • 

    

    Mark Boguniewicz, MD

    Peer

  • 

    

    Eric Simpson, MD, MCR

    Peer

  7

  

  RestartResume

  Using a Biologic in a Patient with Atopic Dermatitis and HSV Keratitis

  Using a Biologic in a Patient with Atopic Dermatitis and HSV Keratitis

  0.25 credits

• • 

    

    Peter A. Lio, MD

    Peer

  • 

    

    Mark Boguniewicz, MD

    Peer

  • 

    

    Eric Simpson, MD, MCR

    Peer

  11

  

  RestartResume

  Options for an Infant with Atopic Dermatitis

  Options for an Infant with Atopic Dermatitis

  0.25 credits

• • 

    

    Michael E. Wechsler, MD, MMSc

    Peer

  8

  

  RestartResume

  Pediatric Asthma: Evidence-Based Approaches in Poorly-Controlled Disease

  Pediatric Asthma: Evidence-Based Approaches in Poorly-Controlled Disease

  0.50 credits

• • 

    

    Joseph K. Han, MD

    Peer

  4

  

  RestartResume

  Sniffing Out the Problem: A Dive into Management for Chronic Rhinosinusitis with Nasal Polyps

  Sniffing Out the Problem: A Dive into Management for Chronic Rhinosinusitis with Nasal Polyps

• • 

    

    Anne O'Donnell, MD

    Peer

  • 

    

    Robert "Brinkley" Sewell

    Peer

  4

  

  RestartResume

  Clinical Exchanges®: Optimizing Management of Nontuberculous Mycobacteria Lung Disease

  Clinical Exchanges®: Optimizing Management of Nontuberculous Mycobacteria Lung Disease

• • 

    

    Anne O'Donnell, MD

    Peer

  • 

    

    Patrick Flume, MD

    Peer

  1

  

  RestartResume

  Clinical Reflections®: Reflecting on Missed Opportunities in Nontuberculous Mycobacteria Lung Disease

  Clinical Reflections®: Reflecting on Missed Opportunities in Nontuberculous Mycobacteria Lung Disease

• • 

    

    Reynold A. Panettieri, Jr., MD

    Peer

  • 

    

    Michael E. Wechsler, MD, MMSc

    Peer

  • 

    

    Jonathan Corren, MD

    Peer

  4

  

  RestartResume

  Advances in the Management of Difficult-to-Treat Asthma

  Advances in the Management of Difficult-to-Treat Asthma

• • 

    

    Peter A. Lio, MD

    Peer

  • 

    

    Eric Simpson, MD, MCR

    Peer

  • 

    

    Mark Boguniewicz, MD

    Peer

  12

  

  RestartResume

  Advances in the Management of Moderate-to-Severe Atopic Dermatitis

  Advances in the Management of Moderate-to-Severe Atopic Dermatitis

• • 

    

    Leora Horn, MD, MSc

    Peer

  3

  

  RestartResume

  Immunotherapy: Changing Patient Outcomes in SCLC

  Immunotherapy: Changing Patient Outcomes in SCLC

• 1
• 2
• Next